-
Alavert Orally Disintegrating Tablets, Alavert Swallow Tablets (Wyeth)
Active Ingredient (in each tablet):
Loratadine 10 mg
Uses:
-
temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:
- runny nose · sneezing · itchy, watery eyes
- itching of the nose or throat
Warnings:
Do not use if you have ever had an allergic reaction to this product or any of its ingredients
Ask a doctor before use if you have liver or kidney disease. Your doctor should determine if you need a different dose.
When using this product do not use more than directed. Taking more than recommended may cause drowsiness.
Stop use and ask a doctor if an allergic reaction to this product occurs. Seek medical help right away.
If pregnant or breast-feeding , ask a health professional before use.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
Directions:
- (orally disintegrating tablet) tablet melts in mouth. Can be taken with or without water.
AgeDoseadults and children 6 years and over1 tablet daily; do not use more than 1 tablet in 24 hourschildren under 6ask a doctorconsumers who have liver or kidney diseaseask a doctorOther Information:
- (orally disintegrating tablet) Phenylketonurics: Contains Phenylalanine 8.4 mg per tablet
- store at 20-25[ordm ]C (68-77[ordm ]F)
- keep in a dry place
Inactive Ingredients (Loratadine orally disintegrating tablets): artificial & natural flavor, aspartame, citric acid, colloidal silicon dioxide, corn syrup solids, crospovidone, magnesium stearate, mannitol, microcrystalline cellulose, modified food starch, sodium bicarbonate
Inactive Ingredients (Loratadine swallow tablets): lactose monohydrate, magnesium stearate, microcrystalline cellulose, sodium starch glycolate
How Supplied: Loratadine orally disintegrating tablets in packages of 6, 12, 24 & 48
How Supplied: Loratadine swallow tablets in packages of 15 and 30 tablets
-
temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:
Subscribe to the "News" RSS Feed
TOP ۞